(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -4.08%122.52B | 8.77%520.34B | 8.53%399.56B | 4.78%266.75B | 4.57%127.73B | 8.33%478.39B | 9.16%368.16B | 12.53%254.59B | 19.72%122.15B | 38.98%441.61B |
Operating income | -4.08%122.52B | 8.77%520.34B | 8.53%399.56B | 4.78%266.75B | 4.57%127.73B | 8.33%478.39B | 9.16%368.16B | 12.53%254.59B | 19.72%122.15B | 38.98%441.61B |
Cost of sales | ---- | -9.00%-508.32B | ---- | -5.01%-260.86B | ---- | -9.62%-466.34B | ---- | -15.05%-248.4B | ---- | -38.26%-425.42B |
Operating expenses | 4.79%-118.5B | -9.00%-508.32B | -8.90%-389.16B | -5.01%-260.86B | -5.04%-124.46B | -9.62%-466.34B | -10.72%-357.37B | -15.05%-248.4B | -20.42%-118.49B | -38.26%-425.42B |
Gross profit | 22.85%4.02B | -0.33%12.02B | -3.66%10.4B | -4.77%5.89B | -10.70%3.27B | -25.54%12.06B | -25.58%10.79B | -40.15%6.18B | 0.60%3.67B | 60.80%16.19B |
Selling expenses | -6.23%-183.5M | 18.48%-358.09M | -4.84%-506.86M | -7.78%-186.74M | -25.22%-172.75M | -19.53%-439.25M | 21.59%-483.47M | -6.77%-173.25M | 23.54%-137.96M | -36.39%-367.46M |
Administrative expenses | -6.30%-553.55M | -7.09%-3.83B | 11.81%-1.57B | -2.07%-1.72B | 2.17%-520.77M | 3.81%-3.57B | 3.62%-1.78B | 1.79%-1.69B | 1.56%-532.3M | -36.26%-3.71B |
Research and development expenses | -70.26%-272.21M | ---- | 3.44%-649.95M | ---- | 26.32%-159.88M | ---- | -9.36%-673.12M | ---- | -116.02%-217M | ---- |
Profit from asset sales | 700.36%143.14K | ---- | -59.74%9.41M | ---- | -99.90%17.89K | ---- | -49.44%23.38M | ---- | 4,828.47%17.23M | ---- |
Revaluation surplus | -125.85%-177.03M | ---- | 1,171.83%533.04M | ---- | 218.27%684.8M | ---- | 89.04%-49.73M | ---- | -2,700.92%-579M | ---- |
-Changes in the fair value of other assets | -125.85%-177.03M | ---- | 1,171.83%533.04M | ---- | 218.27%684.8M | ---- | 89.04%-49.73M | ---- | -2,700.92%-579M | ---- |
Impairment and provision | -90.82%18.19M | 96.41%-10.21M | 70.06%-265.59M | 171.03%94.44M | 7.40%198.06M | 40.71%-284.59M | 35.18%-887.03M | -6.03%-132.95M | 223.00%184.42M | 62.03%-480.02M |
-Other impairment is provision | -90.82%18.19M | 96.41%-10.21M | 70.06%-265.59M | 171.03%94.44M | 7.40%198.06M | 40.71%-284.59M | 35.18%-887.03M | -6.03%-132.95M | 223.00%184.42M | 62.03%-480.02M |
Operating interest expense | ---- | ---- | ---- | -1.72%-1.15B | ---- | ---- | ---- | -8.74%-1.13B | ---- | -3.52%-2.02B |
Special items of operating profit | 130.69%187.86M | 58.57%3.05B | -75.33%132.93M | -18.87%1.51B | -952.94%-612.2M | 194.38%1.92B | 122.86%538.8M | 159.33%1.86B | 106.47%71.78M | -187.94%-2.04B |
Operating profit | 14.59%2.67B | 12.27%10.87B | 7.41%6.92B | -9.89%4.44B | 7.53%2.33B | 27.81%9.68B | -0.48%6.44B | 18.70%4.93B | 59.86%2.17B | 140.26%7.57B |
Financing cost | -78.05%-498.1M | -18.13%-2.32B | -101.35%-433.04M | ---- | -7.04%-279.76M | ---1.97B | 69.40%-215.07M | ---- | -24.55%-261.36M | ---- |
Share of profits of associates | ---- | 152.95%97.96M | ---- | 136.22%46.57M | ---- | -29.78%-185.01M | ---- | -101.62%-128.58M | ---- | -221.84%-142.56M |
Share of profit from joint venture company | ---- | 65.96%-10.33M | ---- | 29.05%-10.86M | ---- | -98.64%-30.34M | ---- | 18.89%-15.3M | ---- | 13.23%-15.27M |
Special items of earning before tax | -15.41%19.98M | ---- | 235.14%37.02M | ---- | 697.10%23.62M | ---- | 57.08%-27.39M | ---- | 56.18%-3.96M | ---- |
Earning before tax | 5.69%2.19B | 15.12%8.63B | 5.22%6.52B | -6.43%4.48B | 9.06%2.08B | 1.10%7.5B | 8.64%6.2B | 17.58%4.78B | 67.30%1.9B | 128.07%7.42B |
Tax | -26.44%-392.92M | -0.09%-1.4B | -2.18%-1.17B | 18.41%-746.91M | 11.78%-310.77M | -1.12%-1.4B | -21.63%-1.15B | -17.85%-915.41M | -33.09%-352.25M | -55.44%-1.39B |
After-tax profit from continuing operations | 2.04%1.8B | 18.58%7.23B | 5.91%5.35B | -3.59%3.73B | 13.79%1.76B | 1.10%6.1B | 6.07%5.05B | 17.51%3.87B | 77.67%1.55B | 155.54%6.03B |
Earning after tax | 2.04%1.8B | 18.58%7.23B | 5.91%5.35B | -3.59%3.73B | 13.79%1.76B | 1.10%6.1B | 6.07%5.05B | 17.51%3.87B | 77.67%1.55B | 155.54%6.03B |
Minority profit | 806.61%85.59M | 412.67%482.31M | 25.96%407.94M | -5.68%255.98M | -87.75%9.44M | -63.38%94.08M | 26.28%323.87M | 96.78%271.39M | 479.17%77.07M | 94.97%256.91M |
Profit attributable to shareholders | -2.29%1.71B | 12.40%6.75B | 4.54%4.94B | -3.44%3.47B | 19.10%1.76B | 3.97%6B | 4.92%4.73B | 14.05%3.6B | 71.45%1.47B | 159.12%5.77B |
Basic earnings per share | -1.96%0.5 | 12.72%1.95 | 4.38%1.43 | -3.85%1 | 18.60%0.51 | 3.59%1.73 | 5.38%1.37 | 14.29%1.04 | 72.00%0.43 | 160.94%1.67 |
Diluted earnings per share | 12.72%1.95 | -3.85%1 | 3.59%1.73 | 14.29%1.04 | 160.94%1.67 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data